It's Halloween ... Biotech Market Spooked in October
Market downturn catches biotech in its wake
02-Nov-2004 -
"The biotech market took a beating
in October, partly because of the general public market experiencing pre-
election jitters, partly in reaction to Merck's Vioxx withdrawal and partly
because Chiron, one of the five top biotech firms in the country, lost nearly
a third of its value over the flu ...
asthma
Chiron
clinical trials
+10